Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Cullinan Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 174
- +23 vs. Q4 2025
- Shares held
- 65.6M
- +5.67M (+9.5%) vs. Q4 2025
- Total value
- $931.0M
- +$311.3M (+50.2%) vs. Q4 2025
- New holders
- 40
- 61 more added
- Sold out
- 17
- 42 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Apis Capital Advisors, LLC | 60,000 | $852.6K | 0.13% | +60,000 | New |
| Tema ETFs LLC | 62,421 | $887.0K | 0.06% | +25,457+68.9% | Added |
| Toroso Investments, LLC | 62,421 | $887.0K | 0.00% | +62,421 | New |
| Mariner, LLC | 62,718 | $891.1K | 0.00% | +13,587+27.7% | Added |
| Engineers Gate Manager LP | 66,288 | $942.0K | 0.01% | −3,055−4.4% | Reduced |
| Rhumbline Advisers | 67,516 | $959.4K | 0.00% | +276+0.4% | Added |
| UBS Asset Management Americas Inc | 67,656 | $961.4K | 0.00% | +19,605+40.8% | Added |
| Rafferty Asset Management, LLC | 69,485 | $987.4K | 0.00% | +7,814+12.7% | Added |
| Quantinno Capital Management LP | 72,282 | $1.03M | 0.00% | +24,281+50.6% | Added |
| Manufacturers Life Insurance Company, The | 75,310 | $1.07M | 0.00% | +58,488+347.7% | Added |
| Qube Research & Technologies Ltd | 90,316 | $1.28M | 0.00% | −28,976−24.3% | Reduced |
| Cinctive Capital Management LP | 94,444 | $1.34M | 0.09% | +94,444 | New |
| Y-Intercept (Hong Kong) Ltd | 95,417 | $1.36M | 0.03% | +95,417 | New |
| Bleichroeder LP | 100,000 | $1.42M | 0.25% | +100,000 | New |
| Moore Capital Management, LP | 105,960 | $1.51M | 0.05% | +105,960 | New |
| Algert Global LLC | 109,731 | $1.56M | 0.02% | −52,770−32.5% | Reduced |
| TD Asset Management Inc | 114,400 | $1.63M | 0.00% | +114,400 | New |
| Assenagon Asset Management S.A. | 138,705 | $1.97M | 0.00% | −20,048−12.6% | Reduced |
| Barclays PLC | 140,295 | $1.99M | 0.00% | −129,360−48.0% | Reduced |
| Bank of New York Mellon Corp | 143,708 | $2.04M | 0.00% | −1,219−0.8% | Reduced |
| American Century Companies Inc | 144,107 | $2.05M | 0.00% | +1,346+0.9% | Added |
| Citigroup Inc | 144,111 | $2.05M | 0.00% | −96,346−40.1% | Reduced |
| Prudential Financial Inc | 149,445 | $2.12M | 0.00% | +149,445 | New |
| Wellington Management Group LLP | 149,626 | $2.13M | 0.00% | −10,125−6.3% | Reduced |
| Schroder Investment Management Group | 173,740 | $2.33M | 0.00% | −169,927−49.4% | Reduced |
| Trexquant Investment LP | 168,473 | $2.39M | 0.02% | −213,062−55.8% | Reduced |
| Longaeva Partners L.P. | 183,691 | $2.61M | 0.13% | +183,691 | New |
| Jump Financial, LLC | 193,800 | $2.75M | 0.04% | −171,089−46.9% | Reduced |
| UBS Group AG | 202,385 | $2.88M | 0.00% | −69,351−25.5% | Reduced |
| PFM Health Sciences, LP | 227,406 | $3.23M | 0.34% | +403+0.2% | Added |
| Susquehanna Portfolio Strategies, LLC | 233,842 | $3.32M | 0.05% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 243,006 | $3.45M | 0.08% | −27,000−10.0% | Reduced |
| Invesco Ltd. | 244,150 | $3.47M | 0.00% | +113,827+87.3% | Added |
| Citadel Advisors LLC | 252,778 | $3.59M | 0.00% | +142,461+129.1% | Added |
| JPMorgan Chase & Co | 297,231 | $3.99M | 0.00% | +150,176+102.1% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 289,115 | $4.11M | 0.01% | +45,093+18.5% | Added |
| Great Point Partners LLC | 300,000 | $4.26M | 1.04% | −334,032−52.7% | Reduced |
| Renaissance Technologies LLC | 324,111 | $4.61M | 0.01% | −307,595−48.7% | Reduced |
| Vanguard Fiduciary Trust Co | 342,852 | $4.87M | 0.00% | +342,852 | New |
| Millennium Management LLC | 346,582 | $4.92M | 0.00% | −15,913−4.4% | Reduced |
| AQR Capital Management LLC | 360,874 | $5.13M | 0.00% | +79,391+28.2% | Added |
| Deutsche Bank AG | 367,906 | $5.23M | 0.00% | −218,730−37.3% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 386,169 | $5.49M | 0.06% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 406,786 | $5.78M | 0.17% | +406,786 | New |
| Soleus Capital Management, L.P. | 410,200 | $5.83M | 0.24% | +410,200 | New |
| Charles Schwab Investment Management Inc | 432,893 | $6.15M | 0.00% | −3,380−0.8% | Reduced |
| Northern Trust Corp | 449,258 | $6.38M | 0.00% | +27,623+6.6% | Added |
| Goldman Sachs Group Inc | 455,449 | $6.47M | 0.00% | −266,415−36.9% | Reduced |
| Bank of America Corp | 516,724 | $7.34M | 0.00% | +170,417+49.2% | Added |
| Two Sigma Investments, LP | 522,047 | $7.42M | 0.01% | +51,521+10.9% | Added |
| Elmind Capital, LP | 530,000 | $7.53M | 2.14% | +220,000+71.0% | Added |
| Vanguard Portfolio Management LLC | 552,553 | $7.85M | 0.00% | +552,553 | New |
| Morgan Stanley | 589,483 | $8.38M | 0.00% | −177,451−23.1% | Reduced |
| Twin Focus Capital Partners, LLC | 595,489 | $8.46M | 0.97% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 781,260 | $11.1M | 0.65% | −1,150,846−59.6% | Reduced |
| Nuveen, LLC | 805,700 | $11.4M | 0.00% | +226,605+39.1% | Added |
| Point72 Asset Management, L.P. | 905,376 | $12.9M | 0.02% | +545,214+151.4% | Added |
| Dimensional Fund Advisors LP | 906,028 | $12.9M | 0.00% | +57,259+6.7% | Added |
| Marshall Wace, LLP | 1,049,581 | $14.9M | 0.02% | +635,222+153.3% | Added |
| Boothbay Fund Management, LLC | 1,112,803 | $15.8M | 0.37% | −124,240−10.0% | Reduced |
| Nextech Invest, Ltd. | 1,141,145 | $16.2M | 1.14% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,193,410 | $17.0M | 0.47% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,368,268 | $19.4M | 0.00% | +66,006+5.1% | Added |
| VR Adviser, LLC | 1,379,965 | $19.6M | 0.73% | 00.0% | Unchanged |
| RTW Investments, LP | 1,705,960 | $24.2M | 0.24% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 1,909,764 | $27.1M | 7.29% | −441,208−18.8% | Reduced |
| Price T Rowe Associates Inc | 2,029,719 | $28.8M | 0.00% | +1,982,532+4,201.4% | Added |
| Vanguard Capital Management LLC | 2,483,034 | $35.3M | 0.00% | +2,483,034 | New |
| State Street Corp | 2,544,115 | $36.2M | 0.00% | +346,777+15.8% | Added |
| Kynam Capital Management, LP | 3,114,132 | $44.3M | 2.81% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,449,966 | $63.2M | 0.00% | +49,670+1.1% | Added |
| BVF Inc | 5,750,683 | $81.7M | 2.60% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 7,648,268 | $108.7M | 8.39% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 8,963,500 | $127.4M | 20.13% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −129,809−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −75,820−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −73,755−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −37,519−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −30,923−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −30,487−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −28,950−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −23,788−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −21,204−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −16,638−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −14,365−100.0% | Sold out |
| Compass Ion Advisors, LLC | 0 | $0 | 0.00% | −13,904−100.0% | Sold out |
| Nano Cap New Millennium Growth Fund L P | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −4,680−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,696−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −218−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |